 | • レポートコード：MRC23Q36063 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のB型肝炎ウイルスRNA検出技術市場について調査・分析し、世界のB型肝炎ウイルスRNA検出技術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（RT PCR技術、RNA等温増幅技術）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Shanghai Rendu Biotechnology、Roche、Abbott、Shengxiang Biotechnology、Thermo Fisher、BGI、Daan Gene、Zhijiang Bio、Soworld Bio、Halotier、Wuhan Zhongqiなどが含まれています。世界のB型肝炎ウイルスRNA検出技術市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、B型肝炎ウイルスRNA検出技術市場規模を推定する際に考慮しました。本レポートは、B型肝炎ウイルスRNA検出技術の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、B型肝炎ウイルスRNA検出技術に関するビジネス上の意思決定に役立てることを目的としています。 ・B型肝炎ウイルスRNA検出技術市場の概要 - B型肝炎ウイルスRNA検出技術のタイプ別セグメント - 世界のB型肝炎ウイルスRNA検出技術市場規模：タイプ別分析（RT PCR技術、RNA等温増幅技術） - B型肝炎ウイルスRNA検出技術の用途別セグメント - 世界のB型肝炎ウイルスRNA検出技術市場規模：用途別分析（病院、クリニック、その他） - 世界のB型肝炎ウイルスRNA検出技術市場規模予測（2018年-2029年） ・B型肝炎ウイルスRNA検出技術市場の成長トレンド - B型肝炎ウイルスRNA検出技術の地域別市場規模（2018年-2029年） - B型肝炎ウイルスRNA検出技術市場ダイナミクス - B型肝炎ウイルスRNA検出技術の業界動向 - B型肝炎ウイルスRNA検出技術市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：RT PCR技術、RNA等温増幅技術 - 世界のB型肝炎ウイルスRNA検出技術のタイプ別市場規模（2018年-2023年） - 世界のB型肝炎ウイルスRNA検出技術のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界のB型肝炎ウイルスRNA検出技術の用途別市場規模（2018年-2023年） - 世界のB型肝炎ウイルスRNA検出技術の用途別市場規模（2024年-2029年） ・B型肝炎ウイルスRNA検出技術の地域別市場規模 - 北米のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - アメリカのB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - ヨーロッパのB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - アジア太平洋のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - 中国のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - 日本のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - 韓国のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - インドのB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - オーストラリアのB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - 中南米のB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） - 中東・アフリカのB型肝炎ウイルスRNA検出技術市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Shanghai Rendu Biotechnology、Roche、Abbott、Shengxiang Biotechnology、Thermo Fisher、BGI、Daan Gene、Zhijiang Bio、Soworld Bio、Halotier、Wuhan Zhongqi ・アナリストの観点/結論 ・調査方法とデータソース |
Serum HBV RNA can better reflect the activity of cccDNA in liver tissue. If the relapse risk of patients is predicted by detecting the level of HBV RNA in serum before drug withdrawal, it will help to identify those who have achieved virological response and are in the “Partially cured” patients who are able to maintain a virological response after drug discontinuation, thereby predicting the risk of virological rebound.
Highlights
The global Hepatitis B RNA Detection Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Hepatitis B RNA Detection Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Hepatitis B RNA Detection Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Hepatitis B RNA Detection Technology in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Hepatitis B RNA Detection Technology include Shanghai Rendu Biotechnology, Roche, Abbott, Shengxiang Biotechnology, Thermo Fisher, BGI, Daan Gene, Zhijiang Bio and Soworld Bio, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis B RNA Detection Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B RNA Detection Technology.
The Hepatitis B RNA Detection Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatitis B RNA Detection Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B RNA Detection Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Shanghai Rendu Biotechnology
Roche
Abbott
Shengxiang Biotechnology
Thermo Fisher
BGI
Daan Gene
Zhijiang Bio
Soworld Bio
Halotier
Wuhan Zhongqi
Segment by Type
RT PCR Technology
RNA Isothermal Amplification Technology
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis B RNA Detection Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B RNA Detection Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 RT PCR Technology
1.2.3 RNA Isothermal Amplification Technology
1.3 Market by Application
1.3.1 Global Hepatitis B RNA Detection Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B RNA Detection Technology Market Perspective (2018-2029)
2.2 Hepatitis B RNA Detection Technology Growth Trends by Region
2.2.1 Global Hepatitis B RNA Detection Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hepatitis B RNA Detection Technology Historic Market Size by Region (2018-2023)
2.2.3 Hepatitis B RNA Detection Technology Forecasted Market Size by Region (2024-2029)
2.3 Hepatitis B RNA Detection Technology Market Dynamics
2.3.1 Hepatitis B RNA Detection Technology Industry Trends
2.3.2 Hepatitis B RNA Detection Technology Market Drivers
2.3.3 Hepatitis B RNA Detection Technology Market Challenges
2.3.4 Hepatitis B RNA Detection Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B RNA Detection Technology Players by Revenue
3.1.1 Global Top Hepatitis B RNA Detection Technology Players by Revenue (2018-2023)
3.1.2 Global Hepatitis B RNA Detection Technology Revenue Market Share by Players (2018-2023)
3.2 Global Hepatitis B RNA Detection Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B RNA Detection Technology Revenue
3.4 Global Hepatitis B RNA Detection Technology Market Concentration Ratio
3.4.1 Global Hepatitis B RNA Detection Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B RNA Detection Technology Revenue in 2022
3.5 Hepatitis B RNA Detection Technology Key Players Head office and Area Served
3.6 Key Players Hepatitis B RNA Detection Technology Product Solution and Service
3.7 Date of Enter into Hepatitis B RNA Detection Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B RNA Detection Technology Breakdown Data by Type
4.1 Global Hepatitis B RNA Detection Technology Historic Market Size by Type (2018-2023)
4.2 Global Hepatitis B RNA Detection Technology Forecasted Market Size by Type (2024-2029)
5 Hepatitis B RNA Detection Technology Breakdown Data by Application
5.1 Global Hepatitis B RNA Detection Technology Historic Market Size by Application (2018-2023)
5.2 Global Hepatitis B RNA Detection Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hepatitis B RNA Detection Technology Market Size (2018-2029)
6.2 North America Hepatitis B RNA Detection Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hepatitis B RNA Detection Technology Market Size by Country (2018-2023)
6.4 North America Hepatitis B RNA Detection Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis B RNA Detection Technology Market Size (2018-2029)
7.2 Europe Hepatitis B RNA Detection Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hepatitis B RNA Detection Technology Market Size by Country (2018-2023)
7.4 Europe Hepatitis B RNA Detection Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B RNA Detection Technology Market Size (2018-2029)
8.2 Asia-Pacific Hepatitis B RNA Detection Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis B RNA Detection Technology Market Size (2018-2029)
9.2 Latin America Hepatitis B RNA Detection Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hepatitis B RNA Detection Technology Market Size by Country (2018-2023)
9.4 Latin America Hepatitis B RNA Detection Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B RNA Detection Technology Market Size (2018-2029)
10.2 Middle East & Africa Hepatitis B RNA Detection Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Rendu Biotechnology
11.1.1 Shanghai Rendu Biotechnology Company Detail
11.1.2 Shanghai Rendu Biotechnology Business Overview
11.1.3 Shanghai Rendu Biotechnology Hepatitis B RNA Detection Technology Introduction
11.1.4 Shanghai Rendu Biotechnology Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.1.5 Shanghai Rendu Biotechnology Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Hepatitis B RNA Detection Technology Introduction
11.2.4 Roche Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Hepatitis B RNA Detection Technology Introduction
11.3.4 Abbott Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Shengxiang Biotechnology
11.4.1 Shengxiang Biotechnology Company Detail
11.4.2 Shengxiang Biotechnology Business Overview
11.4.3 Shengxiang Biotechnology Hepatitis B RNA Detection Technology Introduction
11.4.4 Shengxiang Biotechnology Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.4.5 Shengxiang Biotechnology Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Hepatitis B RNA Detection Technology Introduction
11.5.4 Thermo Fisher Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.5.5 Thermo Fisher Recent Development
11.6 BGI
11.6.1 BGI Company Detail
11.6.2 BGI Business Overview
11.6.3 BGI Hepatitis B RNA Detection Technology Introduction
11.6.4 BGI Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.6.5 BGI Recent Development
11.7 Daan Gene
11.7.1 Daan Gene Company Detail
11.7.2 Daan Gene Business Overview
11.7.3 Daan Gene Hepatitis B RNA Detection Technology Introduction
11.7.4 Daan Gene Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.7.5 Daan Gene Recent Development
11.8 Zhijiang Bio
11.8.1 Zhijiang Bio Company Detail
11.8.2 Zhijiang Bio Business Overview
11.8.3 Zhijiang Bio Hepatitis B RNA Detection Technology Introduction
11.8.4 Zhijiang Bio Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.8.5 Zhijiang Bio Recent Development
11.9 Soworld Bio
11.9.1 Soworld Bio Company Detail
11.9.2 Soworld Bio Business Overview
11.9.3 Soworld Bio Hepatitis B RNA Detection Technology Introduction
11.9.4 Soworld Bio Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.9.5 Soworld Bio Recent Development
11.10 Halotier
11.10.1 Halotier Company Detail
11.10.2 Halotier Business Overview
11.10.3 Halotier Hepatitis B RNA Detection Technology Introduction
11.10.4 Halotier Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.10.5 Halotier Recent Development
11.11 Wuhan Zhongqi
11.11.1 Wuhan Zhongqi Company Detail
11.11.2 Wuhan Zhongqi Business Overview
11.11.3 Wuhan Zhongqi Hepatitis B RNA Detection Technology Introduction
11.11.4 Wuhan Zhongqi Revenue in Hepatitis B RNA Detection Technology Business (2018-2023)
11.11.5 Wuhan Zhongqi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details